MORGAN STANLEY - LANTERN PHARMA INC ownership

LANTERN PHARMA INC's ticker is LTRN and the CUSIP is 51654W101. A total of 26 filers reported holding LANTERN PHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of LANTERN PHARMA INC
ValueSharesWeighting
Q4 2022$1,746
+74.6%
289
-1.7%
0.00%
Q3 2022$1,000
-87.5%
294
-78.9%
0.00%
Q2 2022$8,000
-91.3%
1,394
-89.2%
0.00%
Q1 2022$92,000
-77.6%
12,901
-74.9%
0.00%
Q4 2021$410,000
-23.4%
51,341
+7.1%
0.00%
Q3 2021$535,000
-30.0%
47,928
-8.4%
0.00%
Q2 2021$764,000
-17.0%
52,304
+3.2%
0.00%
Q1 2021$920,000
+71.3%
50,702
+81.6%
0.00%
Q4 2020$537,000
+33.3%
27,917
+30.6%
0.00%
Q3 2020$403,00021,3840.00%
Other shareholders
LANTERN PHARMA INC shareholders Q1 2022
NameSharesValueWeighting ↓
CM Management, LLC 75,000$255,7500.27%
Redmond Asset Management, LLC 46,506$158,5850.06%
Pathway Financial Advisors LLC 32,771$111,7490.04%
CARLSON CAPITAL L P 95,000$323,9500.02%
NewEdge Advisors, LLC 170,031$579,8280.01%
WOLFF WIESE MAGANA LLC 2,200$7,5020.01%
Meridian Wealth Management, LLC 16,660$56,8110.00%
Sigma Planning Corp 18,125$61,8060.00%
HORIZON KINETICS ASSET MANAGEMENT LLC 30,000$102,3000.00%
WELLS FARGO & COMPANY/MN 4,492$15,3180.00%
View complete list of LANTERN PHARMA INC shareholders